The event is deemed to be a reportable malfunction as it is uncertain whether the integrity of the sterile package may have been compromised.The investigation of returned product artegraft (collagen vascular graft) lot number 15h217-002 verified that leakage had occurred but was unable to identify a root cause for the complaint allegation of leaking tube as the returned product was received open.When pressure was applied to the upside down tube no leaks occurred.There was no noticeable damage to the tube or cap.The color of the liquid in the tube should be clear but was tinted yellow and dried brown residue was observed on the tube cap, which may imply that the product was tampered with at the customer site after the shrink wrap was removed from the product tube.The device history record for batch 15h217 was re-reviewed and no related nonconformances were identified; the in-process torque capping machine was within specifications at the time of use and visual inspections and final visual inspections by 2 independent reviews met the requirements at the time of release.No confirmed complaint trends were identified for the issues of leaking tube.To date, no additional complaints were reported from this product batch.The complaint issue will continue to be monitored within artegraft, inc.Quality systems, quality assurance trending.Should additional information become available, a follow-up report will be submitted.
|
Artegraft, inc.Received an email from an authorized distributor stating, "had a customer open a graft to be implanted and some of the sterile solution had leaked out of the bottle prior to being opened." the complaint graft (lot 15h217-002) was not utilized.The procedure was completed with another artegraft (collagen vascular graft).No patient adverse events related to this issue were reported.
|